The work with CD133 in brain tumors was followed by a series of studies supporting the value of CD133 as a marker for identifying and isolating tumor-initiating cells in several other cancers, including pancreas, prostate, lung, liver, and colon tumors [94–99]. The gene discussed is PROM1; the disease is cancer.